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bances and instability of the tear ﬁ lm with possible chang-
es in the ocular surface. They are accompanied by an 
increase in the osmolarity of the tear ﬁ lm and inﬂ amma-
tion of the ocular surface. Damage occurs because of tear 
deﬁ ciency or tear ﬁ lm instability. Dry eye is among the 
most common diseases in ophthalmology with prevalence 
according to different studies between 5 and 34%11. The 
dry eye can be divided in two subgroups: hypovolemic and 
hyperevaporative. Hypovolemic is based on a disorder of 
the aqueous and mucinous layers of the tear ﬁ lm, while 
hyperevaporative is based on a disorder of lipid layer. The 
hypovolemic dry eye is manifested clinically as symptoms 
of a feeling of dryness, feeling of sand or a foreign body in 
the eye and stinging. In contrast, in lipid disorder, patient 
complains of the thickening and redness of the lid margin, 
the eyes often feel tired and symptoms typically occur dur-
ing the course of the day and during stress.
Material and Methods
In this case control study we examined 40 patients 
with unilateral or bilateral pseudoexfoliation on the eyes 
and 40 patients without it as control. Reasons for non-in-
clusion in the study were previous eye surgeries, history 
of recurrent eye inﬂ ammation, diabetes, all of which can 
Pseudoexfoliation syndrome is relatively widespread 
generalized disease of connective tissue in the elderly 
population. Approximately 10% of people over 60 years 
have PEX1–3. Deposition of PEX ﬁ brils in the trabecular 
meshwork makes an important contribution to the occur-
rence of PEX glaucoma. This special form of elastosis ap-
pears to result from interplay between genetic and envi-
ronmental factors in form of a complex disease4,5. Several 
studies in PEX patents showed association with polymor-
phisms in the gene lysyl oxidase like 16,7.
While the PEX syndrome was for long considered a 
speciﬁ c disease of the anterior segment of the eye, today 
it is known to be a generalized process of the extracellular 
matrix8. Using electron microscopy or speciﬁ c immunohis-
tochemical markers, deposits of PEX material can be 
found in numerous organ systems. Also in skin and outer 
ocular tissues especially in conjunctiva9. Increased con-
centration of ﬁ brogenic growth factors, reduced activities 
of proteolytic enzymes, subclinical inﬂ ammatory process-
es and increased oxidative stress are all believed to be 
involved in pathogenesis of this abnormal matrix pro-
cess10.
According to deﬁ nition of Dry Eye Workshop, the term 
dry eye means multifactorial disease of the tears and sur-
face of the eye which leads to symptoms, visual distur-
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inﬂ uence on severity of ocular surface disease, also we 
didn’t include patients who were using any kind of topical 
eye treatment.
Both groups were as similar as possible. Mean age in 
the PEX group was 77.55 years (range 72–85) and for the 
control group 74.72 years (range 69–82). Out of 40 en-
rolled patients with PEX, 37% were males and 63% were 
females. In the control group there was the same number 
of subjects and same gender distribution. The most com-
mon illness in both groups were hypertension and hyper-
lipoproteinemia.
Tear ﬁ lm break-up time test, Schirmer II test and as-
sessment of lid parallel conjunctival folds (LIPCOF) were 
performed to patients in both groups. For determination 
of break-up time, ﬂ uorescein solution was applied to the 
inferior fornix, and the participants were asked to close 
their eyes. Using the blue light of the slit lamp, the time 
in seconds between eyelid opening and the appearance of 
initial defects in the tear ﬁ lm was measured. Schirmer II 
test was performed under local anesthesia with tetracaine 
hydrochloride 1% using paper strips. Measurements were 
taken at the ﬁ fth minute. LIPCOF was evaluated in the 
area on the bulbar conjunctiva above the lower lid with a 
slit-lamp microscope. All tests were performed by same 
experienced ophthalmologist on Department of Ophthal-
mology of University Hospital Centre Zagreb.
Results
The statistical analysis was performed using the Sta-
tistical Package for Social Sciences Version 17.0.1 (SPSS 
Inc., Chicago, Illinois, USA). Data is presented as mean 
value ± standard deviation. The nonparametric Mann-
Whitney U test was used to check the hypotheses if there 
are differences between control and experimental group. 
A p-value less than 0.05 was considered statistically sig-
niﬁ cant.
Statistically signiﬁ cant difference was observed in 
LIPCOF between control and experimental group 
(p<0.01). Subjects in the experimental group had signiﬁ -
cantly higher results (0.87±0.54) than those in the control 
group (0.43±0.35). Two other tests/measures, TBUT and 
Schirmer II test, also showed signiﬁ cant difference be-
tween these groups (p<0.01). Tear break-up time was al-
most three times longer for control group (11.17±4.16) 
compared to experimental (3.97±2.31). Schirmer II test 
found higher results for the control group as well 
(12.91±3.42) than in the experimental group (8.32±3.93).
Discussion
Recent studies have examined the prevalence of dry 
eye in glaucoma and ocular hypertensive patients. Leung 
et al conducted a study on 101 glaucoma patients in order 
to ascertain the prevalence of dry eye. A majority of pa-
tients in that study reported symptoms of dry eye. Schirm-
er tests showed that majority of his patients had a de-
crease in tear production. Abnormal tear quality (reduced 
TBUT) was also observed12.
A large-scale study from Germany, involving 20,506 
patients, analyzed the links between glaucoma, dry eye, 
age, medication, and concomitant disease. Among indi-
viduals with glaucoma, more women than men were re-
ported to develop dry eye. The difference in the frequency 
of dry eye between men and women became more obvious 
after age 50 years. Hypertension, diabetes mellitus, and 
dry mouth, nose, and skin were the most frequent con-
comitant systemic diseases found in the survey. The inci-
dence of dry eye increased with age, the number of IOP-
lowering medications, and the duration of glaucoma13.
Clinical methods of assessing physiologic functions 
that contribute to evaluate ocular surface disease have 
been developed over the past decades. Schirmer II consists 
of placing a ﬁ lter paper strip on the lower lid margin in 
the temporal position of an anesthetized patient. Several 
diagnostic tests evaluate the quantity and quality of the 
tear ﬁ lm. The measurement of TBUT following the instil-
lation of a ﬂ uorescein dye is a widely used technique. More 
sophisticated clinical tests are currently available, which 
may have greater sensitivity for detecting OSD in glau-
coma patients, but they are not widely available. Some of 
the techniques for evaluating the health of the ocular sur-
face (such as dry eye) is computerized videokeratoscopy, 
tear osmolarity and confocal microscopy. Other noninva-
sive techniques, such as aberrometry, have proven to be 
useful for assessing ocular surface health14–17.
In this study, signiﬁ cant differences between two 
groups have been noted. The fact that eyes of the PEX 
group displayed statistically signiﬁ cantly different (abnor-
mal) scores in LIPCOF, Schirmer II and TBUT tests com-
pared to patients in the control group, suggests that PEX 
inﬂ uence tear secretion and stability possibly related with 
conjunctival involvement in the condition. Pseudoexfolia-
tion alters basic features of goblet cell morphology, thus 
affecting tear ﬁ lm stability18. This indicates that pseudo-
exfoliative patients are more likely to develope dry eye 
manifestations. Similar ﬁ ndings were noted in study con-
ducted by Kozobolis et al.19.
Conclusion
Signs and symptoms of ocular surface disease are 
relatively common in older patients, but signs of dry eye 
are signiﬁ cantly higher in individuals who have PEX syn-
drome. There is evidence that topically administered 
medication affects the structure and the integrity of the 
ocular surface. This information should be in mind when 
drugs with benzalkonium chloride or beta blockers are 
prescribed to those patients. In that case, the use of arti-
ﬁ cial tears or preservative free topical therapy could be 
justiﬁ ed.
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BOLEST OČNE POVRŠINE KOD PSEUDOEKSFOLIJACIJSKOG SINDROMA
S A Ž E T A K
Cilj ove studije je utvrditi povezanost između pseudoeksfolijacijskog sindroma (PEX) i simptoma i znakova bolesti 
očne površine. Test vremena pucanja suznog ﬁ lma, Schirmer II test i procjena nabora spojnice paralelnih s rubom vjeđe 
su provedeni kod 40 pacijenata s PEX-om i 40 u kontrolnoj skupini. Svi podaci su statistički analizirani. Rezultati su 
pokazali statistički značajnu razliku među skupinama u svakoj pojedinoj komponenti, najiraženije kod testa vremena 
pucanja suznog ﬁ lma. Zaključili smo da pacijenti s PEX-om imaju veću predispoziciju poremećaja suzne funkcije i da su 
obje komponente sindroma suhog oka prisutne u PEX-u.
